Skip to main content

Advertisement

SpringerLink
Log in

Interactions of the renin-angiotensin system in colorectal cancer and metastasis

  • Review
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

The novel function of the renin-angiotensin system (RAS) is cardiovascular homeostasis. While the major active mediator angiotensin II (ANG II) produces most of the physiologic responses via angiotensin II type I receptor (AT1R), recent insights have looked at the implications of ANG II and its impact on solid tumor formation. Preclinical studies have demonstrated the direct effect of ANG II on the stimulation of angiogenesis via VEGF and other proliferative mediators. RAS components have thus been identified in numerous malignant tissues. Inhibition of the AT1R via angiotensin-converting enzyme inhibitors (ACE-Is) has demonstrated a decrease in solid tumor development and metastasis. Numerous retrospective analyses have demonstrated a reduction in colorectal cancer incidence, polyp formation, and distant metastasis in patients taking inhibitors of the RAS. The use of commonly prescribed anti-hypertensive medications as a chemo-preventative medication may have a remarkable impact in the colorectal cancer community. Further investigation and prospective clinical trials may provide further insight into the potentially beneficial use of ACE-Is and their impact on colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haber E (1976) The role of renin in normal and pathological cardiovascular homeostasis. Circulation 54:849–861

    Article  CAS  PubMed  Google Scholar 

  2. Fyhrquist F, Saijonmaa O (2008) Renin-angiotensin system revisited. J Intern Med 264:224–236

    Article  CAS  PubMed  Google Scholar 

  3. Timmermans P, Chiu AT, Herblin WF, Wong PC, Smith RD (1992) Angiotensin II, receptor subtypes. Amer J of Hyperten 5:406–410

    Article  CAS  Google Scholar 

  4. Timmermans P, Wong PC, Bui AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II, receptors and angiotensin II receptor antagonists. Pharmacol Review 45:205–234

    CAS  Google Scholar 

  5. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1–7) is an endogenous ligand for the G protein-couple receptor Mas. PNAS 2003;100:8258–8263

  6. Escobar E, Rodriguez-Reyna TS, Arrieta O, Sotelo J (2004) Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2:385–399

    Article  CAS  PubMed  Google Scholar 

  7. Ager EI, Neo J, Christophi C (2008) The renin-angiotensin system and malignancy. Carcinogenesis 29:1675–1684

    Article  CAS  PubMed  Google Scholar 

  8. Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K (2004) Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 44:264–270

    Article  CAS  PubMed  Google Scholar 

  9. Tamarat R, Silvestre JS, Duriez M, Levy BI (2002) Angiotensin II, angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82:747–756

    Article  CAS  PubMed  Google Scholar 

  10. De Paepe B et al (2002) Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression. Histochem Cell Biol 117:13–19

    Article  PubMed  Google Scholar 

  11. Uemura H et al (2003) Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2:1139–1147

    CAS  PubMed  Google Scholar 

  12. Fujimoto Y et al (2001) Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Letter 495:197–200

    Article  CAS  Google Scholar 

  13. Takeda H, Kondo S (2001) Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 158:1633–1637

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Kikkawa F et al (2004) Activation of invasiveness of cervical carcinoma cells by angiotensin II. Am J Obstet Gynecol 190:1258–1263

    Article  CAS  PubMed  Google Scholar 

  15. Suganuma T et al (2005) Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 11:2686–2694

    Article  CAS  PubMed  Google Scholar 

  16. Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H (2001) The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: poss role of the vascular endothelial growth factor. Clin Cancer Res 7:1073–1078

    CAS  PubMed  Google Scholar 

  17. Deshayes F, Nahmias C (2005) Angiotensin receptors: a new role in cancer? TRENDS in Endo and Metab 16:293–299

    Article  CAS  Google Scholar 

  18. Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175:409–416

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptors signaling reduces tumor growth, angiogenesis, and metastasis.

  20. Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H (2002) Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem 50:275–282

    Article  CAS  PubMed  Google Scholar 

  21. Mastropaolo M, Zizzo MG, Mule F, Serio R (2013) Angiotensin II contractile effects in mouse colon: role for pre- and post-junctional AT1A receptors. Acta Physiol 207:337–345

    Article  CAS  Google Scholar 

  22. McMenamin UC, Murray LJ, Cantwell MM, Hughes CM (2012) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes Control 23:221–230

    Article  Google Scholar 

  23. Khurana V, Sheth A, Caldito G, Barkin JS. Angiotensin converting enzyme inhibitors reduce the incidence of pancreatic cancer: a study of half a million US Veterans. Gastroenterology 2006;130: Supplement 2 - M2163.

  24. Khurana V, Sheth A, Caldito G, Barkin JS. Angiotensin converting enzyme inhibitors reduce the incidence of esophageal cancer: a study of half a million US Veterans. Gastroenterology 2006;130: Supplement 2 – M2098.

  25. Khurana V, Sheth A, Caldito G, Barkin JS. Angiotensin converting enzyme inhibitors reduce the incidence of colon cancer: a study of half a million US Veterans. Gastroenterology 2006;130: Supplement 2 – S1222.

  26. Mansouri D, McMillan DC, Roxburgh CSD, Crighton EM, Horgan PG (2013) The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening program. Br J Cancer 109:249–256

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Kedika R, Patel M, Pena Sahdala HN, Mahgoub A, Cipher D, Siddiqui AA (2011) Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol 45:e12–e16

    Article  CAS  PubMed  Google Scholar 

  28. Heinzerling JH, Anthony T, Livingston EH, Huerta S (2007) Predictors of distant metastasis and mortality in patients with stage II colorectal cancer. Am Surg 73:230–238

    PubMed  Google Scholar 

  29. Neo JH, Ager EI, Angus PW, Zhu J, Herath CB, Christophi C (2010) Changes in the renin angiotensin system during the development of colorectal cancer liver metastasis. BMC Cancer 10:134

    Article  PubMed Central  PubMed  Google Scholar 

  30. Wen SW, Ager EI, Neo J, Christophi C (2013) The renin angiotensin system regulates Kupffer cells in colorectal liver metastases. Cancer Biol Ther 14:720–727

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C (2007) Effects of ACE inhibitors and angiotensin II receptor antagonist in a mouse model of colorectal cancer liver metastases. J of Gastro and Hepat 22:577–584

    Article  CAS  Google Scholar 

  32. Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J of the National Cancer Institute 97:1679–1687

    Article  Google Scholar 

  33. Luo Y, Ohmori H, Shimomoto T, Fujii K, Sasahira T, Chihara Y, Kuniyasu H (2011) Anti-angiotensin and hypoglycemic treatments suppress liver metastasis of colon cancer cells. Pathobiology 78:285–290

    Article  CAS  PubMed  Google Scholar 

  34. Shimomoto T, Ohmori H, Luo Y, Chihara Y, Denda A, Sasahira T, Tatsumoto N, Fujii K, Kuniyasu H (2012) Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer. Clin Exp Metastasis 29:915–925

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Pinnacle Health System, Harrisburg, PA, 17104, USA

    W. Kurtis Childers

Authors
  1. W. Kurtis Childers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Kurtis Childers.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Childers, W.K. Interactions of the renin-angiotensin system in colorectal cancer and metastasis. Int J Colorectal Dis 30, 749–752 (2015). https://doi.org/10.1007/s00384-014-2118-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-014-2118-1

Keywords

Search

Navigation